Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-30

FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic rabeprazole sodium product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)